A 12-Month–Interval Dosing Study in Adults Indicates That a Single Dose of the National Institute of Allergy and Infectious Diseases Tetravalent Dengue Vaccine Induces a Robust Neutralizing Antibody Response

The ideal dengue vaccine will provide protection against all serotypes of dengue virus and will be economical and uncomplicated in its administration. To determine the ability of a single dose of the live attenuated tetravalent dengue vaccine TV003 to induce a suitable neutralizing antibody response, a placebocontrolled clinical trial was performed in 48 healthy … celý popis

Uloženo v:

Podrobná bibliografie

Publikováno v
The Journal of infectious diseases Ročník 214; číslo 6; s. 832 - 835
Hlavní autoři
Durbin, Anna P., Kirkpatrick, Beth D., Pierce, Kristen K., Carmolli, Marya P., Tibery, Cecilia M., Grier, Palmtama L., Hynes, Noreen, Opert, Kari, Jarvis, Adrienne P., Sabundayo, Beulah P., McElvany, Benjamin D., Sendra, Eli A., Larsson, Catherine J., Jo, Matthew, Lovchik, Janece M., Luke, Catherine J., Walsh, Mary C., Fraser, Ellen A., Subbarao, Kanta, Whitehead, Stephen S.
Typ dokumentu
Journal Article
Jazyk
English
Vydáno
United States Oxford University Press 15. 09. 2016
Edice
Editor's choice
Témata
Adult
Antibodies, Neutralizing - blood
Antibodies, Viral - blood
clinicaltrial
Dengue - immunology
Bibliografie
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Undefined-3
Presented in part: 63rd Annual Meeting of the American Society of Tropical Medicine and Hygiene, New Orleans, Louisiana, November 2014.
A. P. D. and B. D. K. are co–first authors.
ISSN
0022-1899
1537-6613
1537-6613
DOI
10.1093/infdis/jiw067
Dostupnost:
Nápověda
Plný text je dostupný